Drug Profile
Amineptine
Alternative Names: SurvectorLatest Information Update: 29 Apr 2003
Price :
$50
*
At a glance
- Originator Servier
- Developer Pfizer; Servier
- Class Antidepressants; Dibenzocycloheptenes; Small molecules
- Mechanism of Action Dopamine release stimulants; Dopamine uptake inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Marketed Major depressive disorder
Most Recent Events
- 16 Apr 2003 Pharmacia Corporation has been acquired by, and merged into, Pfizer
- 31 Mar 1999 Withdrawn for Depression in Italy (PO)
- 12 Feb 1999 Withdrawn for Depression in Spain (PO)